share_log

新锐医药(06108.HK)将于3月25日举行董事会会议以审批全年业绩

Xinrui Pharmaceuticals (06108.HK) will hold a board meeting on March 25 to approve the annual results

Gelonghui Finance ·  Mar 13 08:06

Gelonghui, March 13, 丨 Xinrui Pharmaceutical (06108.HK) issued an announcement. The board of directors will meet on March 25, 2024 to consider and approve the Group's annual results and publication for the year ended December 31, 2023, and to consider whether to pay a final dividend (if any).

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment